UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis

PloS one, 2016-07, Vol.11 (7), p.e0159384-e0159384

2016

Volltextzugriff (PDF)

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

Arthritis research & therapy, 2023-09, Vol.25 (1), p.1-162, Article 162

2023

Volltextzugriff (PDF)

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study

Arthritis research & therapy, 2020-10, Vol.22 (1), p.1-9, Article 230

2020

Volltextzugriff (PDF)

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Arthritis research & therapy, 2021-07, Vol.23 (1), p.1-204, Article 204

2021

Volltextzugriff (PDF)

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study

BMC cardiovascular disorders, 2018-01, Vol.18 (1), p.16-16, Article 16

2018

Volltextzugriff (PDF)

Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis

Rheumatology (Oxford, England), 2024-02, Vol.63 (2), p.385-391

2024

Volltextzugriff (PDF)

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment

ERJ open research, 2021, Vol.7 (3), p.854

2021

Volltextzugriff (PDF)

Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis

Disability and rehabilitation, 2023-07, Vol.45 (15), p.2517-2525

2023

Volltextzugriff (PDF)

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

The New England journal of medicine, 2019-10, Vol.381 (16), p.1595

2019

Volltextzugriff (PDF)

The Modified Hand Mobility in Scleroderma Test and Skin Involvement - A Followup Study

Journal of rheumatology, 2016-07, Vol.43 (7), p.1356-1362

2016

Volltextzugriff (PDF)

Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

The American journal of pathology, 2002-09, Vol.161 (3), p.939-945

2002

Volltextzugriff (PDF)

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

PloS one, 2009-06, Vol.4 (6), p.e5903

2009

Volltextzugriff (PDF)

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ

Rheumatology (Oxford, England), 2020-05, Vol.59 (5), p.1177-1179

2020

Volltextzugriff (PDF)

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis - a Longitudinal Study

Scientific reports, 2020-04, Vol.10 (1), p.7145-7145, Article 7145

2020

Volltextzugriff (PDF)

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension

Rheumatology (Oxford, England), 2022-01, Vol.61 (1), p.309-318

2022

Volltextzugriff (PDF)

Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis

Rheumatology (Oxford, England), 2015-11, Vol.54 (11), p.2100-2107

2015

Volltextzugriff (PDF)

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

The New England journal of medicine, 2019-10, Vol.381 (16), p.1595-1597

2019

Volltextzugriff (PDF)

Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis

Respiratory medicine, 2013-07, Vol.107 (7), p.1079-1086

2013

Volltextzugriff (PDF)

Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis

Journal of rheumatology, 2014-11, Vol.41 (11), p.2186-2192

2014

Volltextzugriff (PDF)

Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort

Clinical and experimental rheumatology, 2018-01, Vol.36 Suppl 113 (4), p.53

2018

Volltextzugriff (PDF)

Pulmonary blood density quantified by CMR is reduced in newly diagnosed systemic sclerosis, consistent with pulmonary arteriolar proliferation

Journal of cardiovascular magnetic resonance, 2011-02, Vol.13 (S1), p.P387-P387, Article P387

2011

Volltextzugriff (PDF)

Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes

Journal of cardiovascular magnetic resonance, 2013-09, Vol.15 (1), p.86-86, Article 86

2013

Volltextzugriff (PDF)

Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease

Rheumatology (Oxford, England), 2012-05, Vol.51 (5), p.915-920

2012

Volltextzugriff (PDF)

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays

Molecular & cellular proteomics, 2011-05, Vol.10 (5), p.M110.005033-M110.005033, Article M110.005033

2011

Volltextzugriff (PDF)

1 – 25 von 54

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(53)
Tagungsberichte
(1)

Sprache

Englisch
(54)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Metabolic Profiling of Systemic Lupus Erythematosus and Comparison with Primary Sjögren's Syndrome and Systemic Sclerosis

Anti-Ro52 positivity is associated with progressive interstitial lung disease in systemic sclerosis—an exploratory study

Mycophenolate mofetil for systemic sclerosis: drug exposure exhibits considerable inter-individual variation—a prospective, observational study

An open-label study to evaluate biomarkers and safety in systemic sclerosis patients treated with paquinimod

Decreased global myocardial perfusion at adenosine stress as a potential new biomarker for microvascular disease in systemic sclerosis: a magnetic resonance study

Treatment with mycophenolate mofetil is associated with improved nailfold vasculature in systemic sclerosis

Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment

Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease

The Modified Hand Mobility in Scleroderma Test and Skin Involvement - A Followup Study

Differential Expression of Cysteine and Aspartic Proteases during Progression of Atherosclerosis in Apolipoprotein E-Deficient Mice

The Pronounced Th17 Profile in Systemic Sclerosis (SSc) Together with Intracellular Expression of TGFβ and IFNγ Distinguishes SSc Phenotypes

Pulmonary arterial hypertension in systemic sclerosis—when criteria and pathobiology differ

Type III, IV, and VI Collagens Turnover in Systemic Sclerosis - a Longitudinal Study

Circulating plasma microRNAs in systemic sclerosis-associated pulmonary arterial hypertension

Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis

Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease

Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis

Development of a modified hand mobility in scleroderma (HAMIS) test and its potential as an outcome measure in systemic sclerosis

Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort

Pulmonary blood density quantified by CMR is reduced in newly diagnosed systemic sclerosis, consistent with pulmonary arteriolar proliferation

Pulmonary blood volume indexed to lung volume is reduced in newly diagnosed systemic sclerosis compared to normals--a prospective clinical cardiovascular magnetic resonance study addressing pulmonary vascular changes

Increased serum COMP predicts mortality in SSc: results from a longitudinal study of interstitial lung disease

Serum Protein Profiling of Systemic Lupus Erythematosus and Systemic Sclerosis Using Recombinant Antibody Microarrays

A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol

Suchergebnisse filtern